Testosterone and Hemoglobin in Hemodialysis Male and Female Patients

Artificial Organs

Volumn 38, Issue 7, 2014, Pages 598-603

  Ekart, Robert ^a   Taskovska, Milena ^b   Hojs, Nina ^a   Bevc, Sebastjan ^a   Hojs, Radovan ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

End stage renal disease; Female; Gender difference; Hemoglobin; Testosterone

Indexed keywords

BLOOD PRESSURE; BODY FLUIDS; CHOLESTEROL; DIALYSIS; HEMODIALYZERS; LIPOPROTEINS; REGRESSION ANALYSIS;

BODY MASS; DIASTOLIC BLOOD PRESSURES; END-STAGE RENAL DISEASE; FEMALE; GENDER-DIFFERENCES; HAEMODIALYSIS; HAEMOGLOBINS; HEMODIALYSIS PATIENT; SERUM TESTOSTERONE; TESTOSTERONE;

HEMOGLOBIN;

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM; FERRITIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PARATHYROID HORMONE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ANALYTICAL PARAMETERS; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ERYTHROPOIESIS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY DISEASE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; BLOOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; SEX FACTORS; TESTOSTERONE;

EID: 84904395319     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12218     Document Type: Article

References (16)

1. Parker JP, Beime GJ, Desai JN, Raich PC, Shahidi NT. Androgen-induced increase in red-cell 2, 3-diphosphoglycerate. N Engl J Med 1972;287:381-383.
2. Sheashaa H, Abdel-Razek W, El-Husseini A, Mohamed Taha N, Elbaz M, Sobh M. Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis. Nephron Clin Pract 2005;99:c102-106.
3. Buttner R, Bollheimer LC, Zietz B, et al. Definition and characterization of relative hypo- and hyperleptinemia in a large Caucasian population. J Endocrinol 2002;175:745-756.
4. Bachman E, Feng R, Travison T, et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 2010;95:4743-4747.
5. Moriyama Y, Fischer JW. Increase in erythroid colony formation in rabbits following the administration of testosterone. Proc Soc Exp Biol Med 1975;149:178-180.
6. Carrero JJ, Barany P, Yilmaz MI, et al. Testosterone deficiency is a cause of anemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease. Nephrol Dial Transplant 2012;27:709-715.
7. Ferrucci L, Maggio M, Bandinelli S, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006;166:1380-1388.
8. Anantharaman P, Schmidt RJ. Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 2007;14:119-125.
9. Bhatia V, Chaudhuri A, Tomar R, Dhindsa S, Ghanim H, Dandona P. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care 2006;29:2289-2294.
10. Grossmann M, Panagiotopolou S, Sharpe K, et al. Low testosterone and anaemia in men with type 2 diabetes. Clin Endocrinol (Oxf) 2009;70:547-553.
11. Shaldon S, Koch KM, Oppermann F, Patyna WD, Schoeppe W. Testosterone therapy for anemia in maintenance dialysis. Br Med J 1971;3:212-215.
12. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012;2:279-335.
13. Carrero JJ, Steinvinkel P. The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant 2012;27:4030-4041.
14. Griggs RC, Kingston W, Jozefowich RF, Herr BE, Forbes G, Halliday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 1989;66:498-503.
15. Carrero JJ, Qureshi AR, Parini P, et al. Low serum testosterone increases mortality risk among male dialysis patients. J Am Soc Nephrol 2009;20:613-620.
16. Carrero JJ, Qureshi AR, Nakashima A, et al. Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transplant 2011;26:184-190.